These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29127457)

  • 21. The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanism.
    Hou Z; Gangjee A; Matherly LH
    FASEB J; 2022 Feb; 36(2):e22164. PubMed ID: 35061292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton-coupled folate transporter as a biomarker of outcome to treatment for pleural mesothelioma.
    Petri GL; Cascioferro S; Parrino B; Peters GJ; Diana P; Giovannetti E
    Pharmacogenomics; 2018 Jul; 19(10):811-814. PubMed ID: 29916298
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.
    Golani LK; Wallace-Povirk A; Deis SM; Wong J; Ke J; Gu X; Raghavan S; Wilson MR; Li X; Polin L; de Waal PW; White K; Kushner J; O'Connor C; Hou Z; Xu HE; Melcher K; Dann CE; Matherly LH; Gangjee A
    J Med Chem; 2016 Sep; 59(17):7856-76. PubMed ID: 27458733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).
    Visentin M; Unal ES; Najmi M; Fiser A; Zhao R; Goldman ID
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C631-41. PubMed ID: 25608532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A P425R mutation of the proton-coupled folate transporter causing hereditary folate malabsorption produces a highly selective alteration in folate binding.
    Shin DS; Zhao R; Yap EH; Fiser A; Goldman ID
    Am J Physiol Cell Physiol; 2012 May; 302(9):C1405-12. PubMed ID: 22345511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activity of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as inhibitors of de novo purine biosynthesis with selectivity for cellular uptake by high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier.
    Wang L; Cherian C; Kugel Desmoulin S; Mitchell-Ryan S; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2012 Feb; 55(4):1758-70. PubMed ID: 22243528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and Enzymatic Analysis of Tumor-Targeted Antifolates That Inhibit Glycinamide Ribonucleotide Formyltransferase.
    Deis SM; Doshi A; Hou Z; Matherly LH; Gangjee A; Dann CE
    Biochemistry; 2016 Aug; 55(32):4574-82. PubMed ID: 27439469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of antifolate recognition and transport by PCFT.
    Parker JL; Deme JC; Kuteyi G; Wu Z; Huo J; Goldman ID; Owens RJ; Biggin PC; Lea SM; Newstead S
    Nature; 2021 Jul; 595(7865):130-134. PubMed ID: 34040256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substituted cysteine accessibility reveals a novel transmembrane 2-3 reentrant loop and functional role for transmembrane domain 2 in the human proton-coupled folate transporter.
    Wilson MR; Hou Z; Matherly LH
    J Biol Chem; 2014 Sep; 289(36):25287-95. PubMed ID: 25053408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and functional impact of homo-oligomers of the human proton-coupled folate transporter.
    Hou Z; Kugel Desmoulin S; Etnyre E; Olive M; Hsiung B; Cherian C; Wloszczynski PA; Moin K; Matherly LH
    J Biol Chem; 2012 Feb; 287(7):4982-95. PubMed ID: 22179615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.
    Zhao R; Aluri S; Goldman ID
    Mol Aspects Med; 2017 Feb; 53():57-72. PubMed ID: 27664775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier.
    Zhao R; Qiu A; Tsai E; Jansen M; Akabas MH; Goldman ID
    Mol Pharmacol; 2008 Sep; 74(3):854-62. PubMed ID: 18524888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of the Arg376 residue of the proton-coupled folate transporter (PCFT-SLC46A1) and a glutamine mutant causing hereditary folate malabsorption.
    Mahadeo K; Diop-Bove N; Shin D; Unal ES; Teo J; Zhao R; Chang MH; Fulterer A; Romero MF; Goldman ID
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1153-61. PubMed ID: 20686069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.
    Zhao R; Visentin M; Goldman ID
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1163-73. PubMed ID: 25847479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.
    Zamek-Gliszczynski MJ; Zhang X; Mudunuru J; Du Y; Chen JL; Taskar KS; Huang J; Huang Y; Romach EH
    Drug Metab Dispos; 2019 Aug; 47(8):890-898. PubMed ID: 31167838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the tryptophan residues in proton-coupled folate transporter (PCFT-SLC46A1) function.
    Najmi M; Zhao R; Fiser A; Goldman ID
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C150-7. PubMed ID: 27251438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the proton-coupled folate transporter (PCFT-SLC46A1) by bicarbonate and other anions.
    Zhao R; Visentin M; Suadicani SO; Goldman ID
    Mol Pharmacol; 2013 Jul; 84(1):95-103. PubMed ID: 23609145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed.
    Zhao R; Goldman ID
    Cancer Metastasis Rev; 2007 Mar; 26(1):129-39. PubMed ID: 17340171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression.
    Zhao R; Diop-Bove N; Goldman ID
    Mol Pharmacol; 2014 Feb; 85(2):310-21. PubMed ID: 24249723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.